Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Arterial Hypertension.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07266519
What this trial is testing

SIRIUS - Initial Combination Therapy With an Endothelin Receptor Antagonist, a Phosphodiesterase-5 Inhibitor and Sotatercept in Patients With Newly Diagnosed Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension (PAH)
Philipps University Marburg 25
Not applicableUnknownNCT01905189
What this trial is testing

Resynchronisation Therapy of Right Ventricle in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
University Hospital, Caen 15
Large-scale testing (Phase 3)UnknownNCT01637675
What this trial is testing

Efficacy and Safety Study of Sodium Tanshinone IIA Sulfonate on Pulmonary Hypertension

Who this might be right for
Pulmonary HypertensionPulmonary Arterial HypertensionCardiovascular Diseases+2 more
The First Affiliated Hospital of Guangzhou Medical University 90
Very early researchStudy completedNCT01100736
What this trial is testing

Role of Endothelin-A (ETA) and Endothelin-B (ETB) Receptors in the Vasodilatory Response to Endothelin-3 (ET-3)

Who this might be right for
Pulmonary Arterial HypertensionVasodilationVasoconstriction
University of Edinburgh 10
Large-scale testing (Phase 3)Study completedNCT02112487
What this trial is testing

Extension of the Psychometric Validation Study ORCHESTRA in Patients With PAH

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 88
Not applicableStudy completedNCT01977014
What this trial is testing

NIMS- New Implantable Pump in Pulmonary Arterial Hypertension, a Safety Follow up

Who this might be right for
Pulmonary Hypertension Group 1 and 4 According to Nice Classification
NordicInfu Care AB 40
Not applicableUnknownNCT06072937
What this trial is testing

IntelliStent for Pulmonary Flow Adjustment in Congenital Heart Disease and Dilated Cardiomyopathy

Who this might be right for
Pulmonary Arterial HypertensionDilated CardiomyopathyCongenital Heart Disease
HeartPoint Global 10
Not applicableWithdrawnNCT02278445
What this trial is testing

Evaluation of Pulmonary Doppler Signals in Patients With Systemic Sclerosis(SSc)

Who this might be right for
Systemic SclerosisPulmonary Hypertension
Echosense Ltd.
Testing effectiveness (Phase 2)Active Not RecruitingNCT04816604
What this trial is testing

Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension
Gossamer Bio USA, Inc. 74
Not applicableStudy completedNCT02799771
What this trial is testing

HYPID (Pulmonary Hypertension in Interstitial Lung Disease) EXTENSION

Who this might be right for
Pulmonary Arterial HypertensionDiffuse Interstitial Lung Disease
Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires 210
Not applicableStudy completedNCT04094272
What this trial is testing

Pulmonary Arterial Hypertension in Patients With Direct-Acting Antiviral Medications for Hepatitis C Virus Infection

Who this might be right for
Pulmonary Artery HypertensionChronic Hepatitis c
Kantonsspital Olten 49
Not applicableLooking for participantsNCT05745961
What this trial is testing

Quantifying 18kDa TSPO Expression in the Lung in Pulmonary Artery Hypertension (PAH)

Who this might be right for
Pulmonary Arterial HypertensionHealthy
Imperial College London 6
Testing effectiveness (Phase 2)Ended earlyNCT01725256
What this trial is testing

Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension
Aires Pharmaceuticals, Inc. 29
Large-scale testing (Phase 3)Study completedNCT05167825
What this trial is testing

Macitentan in Japanese Pediatric Participants With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Janssen Pharmaceutical K.K. 7
Not applicableStudy completedNCT00926523
What this trial is testing

Biomarkers in the Evaluation of Chronic Lung Disease

Who this might be right for
Pulmonary HypertensionPulmonary Arterial HypertensionInterstitial Lung Disease
Northwell Health 67
Testing effectiveness (Phase 2)Study completedNCT01457781
What this trial is testing

Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial HypertensionPulmonary Hypertension
Bellerophon Pulse Technologies 80
Not applicableStudy completedNCT06550648
What this trial is testing

Evaluation of the Role of Epstein-Bar Virus in Patients With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Cairo University 78
Post-approval studies (Phase 4)Study completedNCT02847260
What this trial is testing

Safety and Tolerability of Rapid Dose Titration of Subcutaneous Remodulin® Therapy in PAH Subjects (RAPID)

Who this might be right for
Pulmonary Arterial Hypertension
United Therapeutics 39
Not applicableStudy completedNCT06819059
What this trial is testing

Safety and Effectiveness of a Virtual Pediatric Cardiac Rehabilitation Program or Telerehabilitation in Children With Heart Disease

Who this might be right for
Congenital AbnormalitiesPulmonary Arterial Hypertension (PAH)Orthotopic Heart Transplant+4 more
Columbia University 50
Testing effectiveness (Phase 2)WithdrawnNCT06643143
What this trial is testing

IkT-001Pro in Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension (PAH)Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)
Inhibikase Therapeutics
Next Page